More than one year after the consumer advocacy group Public Citizen petitioned the FDA to issue an Ortho Evra recall, the birth control patch remains on the market and many healthy young women continue to be exposed to a risk of serious and potentially fatal blood clots, which could result… Read more.
Since the FDA approved NuvaRing birth control as a once-monthly vaginal contraceptive ring in October 2001, Organon USA has continued to provide inadequate and insufficient warnings about the risk of potentially life-threatening blood clots that may result in heart attacks, strokes, pulmonary embolism, deep vein thrombosis or death. The NuvaRing… Read more.
The birth control Nuva Ring has been associated with an increased risk of blood clots, which could cause otherwise healthy young women to suffer deep vein thrombosis (DVT), pulmonary embolism, heart attacks, strokes or death. However, many women remain unaware of these potential NuvaRing problems, as the manufacturer has failed… Read more.
Despite concerns that have surfaced in the United States about NuvaRing side effects which may increase the risk of potentially fatal blood clots, the birth control ring has been approved in the U.K. as a once-monthly alternative to the birth control pill.
The Ortho Evra attorneys at Saiontz & Kirk, P.A. have been representing women who suffered severe and life-threatening blood clot injuries as a result of the birth control patch since 2005. Although Bloomberg News publicly reported Friday that hundreds of cases have settled confidentially, our attorneys continue to investigate new… Read more.
The product liability attorneys at Saiontz & Kirk, P.A. are now reviewing potential NuvaRing birth control lawsuits for users of the contraceptive ring. Many otherwise healthy young women have suffered severe blot clot injuries, such as heart attacks, strokes, pulmonary embolysm snd deep vein thrombosis, as a result of NuvaRing… Read more.
Today the FDA received a petition filed by Public Citizen Health Research Group asking that the agency issue an Ortho Evra recall. The consumer advocacy group asked the FDA to remove the birth control patch from the market due to the risk of serious and potentially fatal injury associated with… Read more.
According to federal court filings in the Ortho Evra litigation, Johnson & Johnson hid data from the FDA about their birth control patch’s side effects and failed to address flaws in the manufacturing process which could increase the risk of serious and potentially fatal problems. Although lawyers for both sides… Read more.
Late Friday afternoon, the FDA and Johnson & Johnson announced that the warning label for Ortho Evra will be strengthened to include new information from a study which confirms users of the birth control patch face an increased risk of serious and potentially fatal blood clots, known as venous thromboembolism… Read more.
Bloomberg News reports that Johnson & Johnson has agreed to pay $1.25 million to settle one Ortho Evra birth control patch lawsuit. The details of the confidential agreement were made public after the news agency received a copy of settlement documents from a court clerk. Although it was known that… Read more.
